The Association Between Metabolic Dysfunction‐Associated Steatotic Liver Disease and Change in Liver Stiffness in Patients With Chronic Hepatitis B
Liver International · 2025
DOI: 10.1111/liv.70042 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Liver International, 2025. Verfasst von Lesley A Patmore und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Liver, Fatty Liver, Liver Cirrhosis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stichting voor Lever- en Maag-Darm Onderzoek, Gilead Sciences.
Abstract (Originalsprache)
Background and Aims Metabolic dysfunction‐associated steatotic liver disease (MASLD) is associated with an increased risk of liver‐related events in patients with chronic hepatitis B (CHB), possibly by accelerating fibrosis progression. Therefore, we studied the influence of MASLD on liver stiffness measurement (LSM) kinetics in CHB patients.
Methods
We conducted a multicenter retrospective cohort study of CHB patients with at least two LSM with FibroScan. We studied the absolute change in LSM and the change in LSM stage from the first LSM to the most recent LSM among CHB patients with MASLD compared to patients without MASLD.
Results
We analysed 1055 CHB patients; 259 (28.0%) had MASLD. Patients with MASLD had a higher first and last LSM (6.1 vs. 5.2 kPa and 5.6 vs. 4.7 kPa, p < 0.001), were significantly less likely to achieve a decrease in LSM stage (52.8% vs. 74% p < 0.001) and were more likely to experience an increase in LSM stage (19.3% vs. 13.6%, p = 0.035) during follow‐up. 417 (39.5%) patients initiated antiviral therapy (AVT) which was associated with a decline in LSM ( p < 0.001). However, patients with MASLD who were treated were less likely to decrease in LSM stage (52.4% vs. 77.0%, p < 0.001) and were more likely to experience an increase in LSM stage (23.5% vs. 12.8%, p = 0.021) despite AVT.
Conclusion
Presence of MASLD was independently associated with higher LSM in untreated CHB patients and with less decline in LSM after initiation of AVT. Furthermore, CHB patients with MASLD were more likely to experience an increase in LSM despite AVT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
- Department of Gastroenterology and Hepatology, Amsterdam UMC, Amsterdam, the Netherlands.
- Department of Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, the Netherlands.
- Toronto Center for Liver Disease, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.
- Department of Pathology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands.
- Department of Gastroenterology and Hepatology, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
ORCID-Profile: Lesley A Patmore, Özgür M Koc, Willem P Brouwer, Milan J Sonneveld
Förderung
- Stichting voor Lever- en Maag-Darm Onderzoek
- Gilead Sciences
Zitieren
APA
Patmore, L. A., van Eekhout, K., Koc, Ö. M., de Knegt, R. J., Janssen, H. L. A., Brouwer, W. P., Kramer, M., Honkoop, P., de Bruijne, J., Boland, G. J., Postma, D. F., Blokzijl, H., de Man, R. A., Takkenberg, R. B., & Sonneveld, M. J. (2025). The Association Between Metabolic Dysfunction‐Associated Steatotic Liver Disease and Change in Liver Stiffness in Patients With Chronic Hepatitis B. Liver International. https://doi.org/10.1111/liv.70042
Vancouver
Patmore LA, van Eekhout K, Koc ÖM, de Knegt RJ, Janssen HLA, Brouwer WP, et al. The Association Between Metabolic Dysfunction‐Associated Steatotic Liver Disease and Change in Liver Stiffness in Patients With Chronic Hepatitis B. Liver International. 2025. doi:10.1111/liv.70042
BibTeX
@article{Patmore2025,
author = {Patmore, Lesley A and van Eekhout, Kirsi and Koc, Özgür M and de Knegt, Robert J and Janssen, Harry L A and Brouwer, Willem P and Kramer, Matthijs and Honkoop, Pieter and de Bruijne, Joep and Boland, Greet J and Postma, Douwe F and Blokzijl, Hans and de Man, Robert A and Takkenberg, R Bart and Sonneveld, Milan J},
title = {The Association Between Metabolic Dysfunction‐Associated Steatotic Liver Disease and Change in Liver Stiffness in Patients With Chronic Hepatitis B},
journal = {Liver International},
year = {2025},
doi = {10.1111/liv.70042}
}
EUVIMED